Your browser doesn't support javascript.
loading
Intranasal delivery of a chimpanzee adenovirus vector expressing a pre-fusion spike (BV-AdCoV-1) protects golden Syrian hamsters against SARS-CoV-2 infection.
Wang, Shen; Xu, Long; Mu, Ting; Qin, Mian; Zhao, Ping; Xie, Liang; Du, Linsen; Wu, Yue; Legrand, Nicolas; Mouchain, Karine; Fichet, Guillaume; Liu, Yi; Yin, Wenhao; Zhao, Jin; Ji, Min; Gong, Bo; Klein, Michel; Wu, Ke.
Afiliação
  • Wang S; Regularoty and Medical Affairs Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Xu L; Project Management Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Mu T; Innovative Discovery Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Qin M; Project Management Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Zhao P; Test Development Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Xie L; Innovative Discovery Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Du L; China Office, Voisin Consulting Life Sciences, Shanghai, China.
  • Wu Y; Test Development Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Legrand N; In Vivo Sciences Department, Oncodesign, Centre François Hyafil, Villebon-sur-Yvette, France.
  • Mouchain K; DMPK & Bioanalytical Sciences Department, Oncodesign, Centre François Hyafil, Villebon-sur-Yvette, France.
  • Fichet G; In Vitro Sciences Department, Oncodesign, Centre François Hyafil, Villebon-sur-Yvette, France.
  • Liu Y; Project Management Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Yin W; State Key Laboratory of Biocatalysts and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, China.
  • Zhao J; Project Management Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Ji M; Test Development Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Gong B; Regularoty and Medical Affairs Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Klein M; Regularoty and Medical Affairs Department, Wuhan BravoVax Co., Ltd., Wuhan, China.
  • Wu K; Executive Office, Wuhan BravoVax Co., Ltd., Wuhan, China.
Front Cell Infect Microbiol ; 12: 979641, 2022.
Article em En | MEDLINE | ID: mdl-36405962
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article